Indiva organizacji Net debt/EBITDA
Jaka jest wartość Net debt/EBITDA organizacji Indiva?
Wartość Net debt/EBITDA organizacji Indiva Ltd. to -13.08
Jaka jest definicja Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA firm w Health Care sektor na TSXV w porównaniu do Indiva
Czym się zajmuję organizacja Indiva?
Indiva Limited operates as a licensed producer of cannabis products in Canada. It creates premium pre-rolls, flower, capsules, and edible products, as well as provides production and manufacturing services to peer entities. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Ruby Cannabis Sugar, Sapphire Cannabis Salt, Artisan Batch, and other powered by INDIVA products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.
Firmy z net debt/ebitda podobne do Indiva
- Wartość Net debt/EBITDA organizacji ECO Animal Health plc to -13.13
- Wartość Net debt/EBITDA organizacji Global Sweeteners to -13.12
- Wartość Net debt/EBITDA organizacji Taylor Devices to -13.09
- Wartość Net debt/EBITDA organizacji OSE Immunotherapeutics SA to -13.09
- Wartość Net debt/EBITDA organizacji Kamada Ltd to -13.09
- Wartość Net debt/EBITDA organizacji AM to -13.09
- Wartość Net debt/EBITDA organizacji Indiva to -13.08
- Wartość Net debt/EBITDA organizacji Echelon to -13.07
- Wartość Net debt/EBITDA organizacji Inseego to -13.05
- Wartość Net debt/EBITDA organizacji Cipher Pharmaceuticals to -13.05
- Wartość Net debt/EBITDA organizacji IXICO plc to -13.03
- Wartość Net debt/EBITDA organizacji Altair Engineering Inc to -13.00
- Wartość Net debt/EBITDA organizacji Avio S.p.A to -13.00